+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure

Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure

Quality of Life Research 24(12): 3001-3014

Diabetic peripheral neuropathy (DPN) occurs in 26-47 % of diabetes patients and may have negative impacts on physical functioning, sleep, well-being, and quality of life. The Diabetic Peripheral Neuropathic Pain Impact measure (DPNPI) was developed to measure disease impacts and treatment effects. Presented are the DPNPI conceptual development and validation findings. The DPNPI was developed following the FDA Guidance for Industry on patient-reported outcome (PRO) measures. Concept elicitation (CE) included literature review, clinical expert interviews, and patient interviews/focus groups. Qualitative data were analyzed following grounded theory principles, and draft items were cognitively debriefed. The measure underwent psychometric validation, and an a priori statistical analysis plan assessed the measurement model, reliability, and validity. Simultaneous analyses of item functioning were conducted using Rasch measurement theory (RMT). All tests were performed for the total score and each domain. Twenty-five patients and three clinical experts participated in CE which resulted in a 27-item validation ready measure. In the validation study (N = 124), nine draft items were dropped due to high missing data and/or high correlations between items. Factor analysis revealed three domains: physical functioning/mobility, sleep, and daily activities. RMT confirmed adequate item fit and placement within domains. Internal consistency ranged from 0.91 to 0.96 and test-retest from 0.84 to 0.91. All prespecified hypotheses for convergent and discriminant validity were met. CE and psychometric results provide evidence that the final, 18-item DPNPI is a reliable and valid PRO measure of disease impacts and treatment for DPNP. Further validation work should include responsiveness assessment.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057598099

Download citation: RISBibTeXText

PMID: 26068732

DOI: 10.1007/s11136-015-1037-0

Related references

The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy. Quality of Life Research 21(7): 1255-1266, 2012

Development and Validation of A Patient-Reported Outcome Measure of the Psychological Impact of Submental Fat. Value in Health 18(7): A412, 2015

Validation of a Patient-reported Outcome (PRO) Measure and a Clinician-reported Outcome (CRO) Measure to Assess Satisfaction with Pharmacologic Stress Agents for Single-photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI). Clinical Therapeutics 38(5): 1141-1150, 2016

Development of a new patient-reported outcome (PRO) measure on the Impact of Nighttime Urination (INTU) in patients with nocturia-Psychometric validation. Neurourology and Urodynamics 37(5): 1678-1685, 2018

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer. Quality of Life Research 27(1): 59-74, 2018

Development and validation of a patient-centered outcome measure for young adults with pediatric hip conditions: the Quality of Life, Concerns and Impact Measure. Patient Related Outcome Measures Volume 10: 187-204, 2019

Development and validation of a new patient-reported outcome measure for peripheral nerve disorders of the hand, the I-HaND© Scale. Journal of Hand Surgery European Volume 43(8): 864-874, 2018

The use of a self-reported pain measure, a nurse-reported pain measure and the PAINAD in nursing home residents with moderate and severe dementia: a validation study. Age and Ageing 35(3): 252-256, 2006

Development and validation of a patient-reported outcome measure for stroke patients. Health and Quality of Life Outcomes 13: 53, 2015

The patient-reported impact of scars measure: development and validation. Plastic and Reconstructive Surgery 125(5): 1439-1449, 2010

The colostomy impact score: development and validation of a patient reported outcome measure for rectal cancer patients with a permanent colostomy. A population-based study. Colorectal Disease 19(1): O25-O33, 2017

Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back pain. Medical Decision Making 34(7): 873-883, 2014

Development and Validation of the Keele Musculoskeletal Patient Reported Outcome Measure (MSK-PROM). Plos one 10(4): E0124557, 2015

Development and validation of Patient Reported Impact of Spasticity Measure (PRISM). Journal of Rehabilitation Research and Development 44(3): 363-371, 2007

Development and validation of a new patient-reported outcome measure for patients with pressure ulcers: the PU-QOL instrument. Health and Quality of Life Outcomes 11: 95, 2013